GoodRx Holdings (GDRX) Change in Account Payables (2019 - 2026)

GoodRx Holdings has disclosed Change in Account Payables across 8 years of filings, most recently posting -$4.9 million for Q2 2026.

• In Q2 2026, Change in Account Payables fell 249.59% year-over-year to -$4.9 million; the TTM figure through Jun 2026 stood at -$9.3 million (down 261.8% YoY), while the FY2025 annual figure was $4.1 million, up 125.94% from the prior year.
• Change in Account Payables came in at -$4.9 million for Q2 2026 at GoodRx Holdings, roughly flat from -$4.9 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $25.5 million in Q3 2023 to a low of -$15.6 million in Q2 2024.
• Average Change in Account Payables over 5 years is -$579277.8, with a median of -$3.5 million recorded in 2022.
• Year-over-year, Change in Account Payables soared 10030.77% in 2022 and plunged 1829.02% in 2026.
• Over 5 years, Change in Account Payables stood at $7.1 million in 2022, then tumbled by 134.76% to -$2.5 million in 2023, then soared by 396.17% to $7.3 million in 2024, then sank by 243.2% to -$10.5 million in 2025, then jumped by 53.18% to -$4.9 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$4.9 million in Q2 2026, -$4.9 million in Q1 2026, and -$10.5 million in Q4 2025.